Recombinant Frog virus 3 Uncharacterized protein 094L (FV3-094L)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Frog Virus 3 Uncharacterized Protein 094L (FV3-094L)

Recombinant Frog Virus 3 Uncharacterized Protein 094L (FV3-094L) is a protein encoded by the Frog Virus 3 (FV3), a member of the Ranaviruses genus within the family Iridoviridae. FV3 is known for infecting cold-blooded animals such as amphibians, fish, and reptiles . Despite its significance, specific information about the FV3-094L protein is limited, and it is categorized as an uncharacterized protein. This article aims to provide an overview of what is known about FV3 and its proteins, highlighting the broader context in which FV3-094L exists.

Background on Frog Virus 3 (FV3)

FV3 is a large double-stranded DNA virus with a genome size of approximately 105 kb, containing nearly 100 coding genes and 50 intergenic regions . It was first reported in leopard frogs in the 1960s and has been associated with significant morbidity and mortality in amphibian populations worldwide . The virus has been isolated from both sick and healthy frogs, indicating its ability to persist in hosts without causing immediate disease .

Research on FV3 Proteins

While specific studies on FV3-094L are not available, research on other FV3 proteins has provided insights into the virus's mechanisms of infection and interaction with host cells. For example, the FV3orf64R gene encodes a protein involved in immune evasion and regulation of viral gene expression . The disruption of this gene in mutant viruses affects viral replication and transcription dynamics .

Data and Research Findings

Viral ProteinFunctionHost Interaction
FV3orf64RImmune evasion, regulation of viral gene expressionInteracts with host transcription factors
Other FV3 proteinsVarious roles in viral replication and host interactionPotential interaction with host immune response

Future Research Directions

Future studies should focus on characterizing uncharacterized proteins like FV3-094L to understand their roles in the viral life cycle and host-virus interactions. This could involve genetic manipulation of the virus to study the effects of protein deletion or mutation on viral replication and pathogenicity.

Product Specs

Form
Lyophilized powder Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering. We will accommodate your request whenever possible.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates. Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. The tag type is determined during the production process. If you require a specific tag type, please inform us; we will prioritize its development.
Synonyms
FV3-094LUncharacterized protein 094L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-155
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Frog virus 3 (isolate Goorha) (FV-3)
Target Names
FV3-094L
Target Protein Sequence
MDPEGMMYGF GVSFGISWAI LKLFGREKKG KDRPREDGTQ QQPSESKGEA ACRDAAYRIT GKRFEKIRHK GIVNPDTGRA LELDCYSKSL KTAIEYQGRQ HYEYVSVFHK GGRQDLRKQH ERDCYKRAAC QKLGIKLIEV PYTVKDIEGY LRKVL
Uniprot No.

Q&A

What is FV3-094L and what do we currently know about it?

FV3-094L is an uncharacterized protein encoded by Frog Virus 3, classified as a P8.141C-like protein based on sequence homology. Transcriptomic analyses have identified it as an immediate early stable (IE-S) gene, meaning it is expressed early in infection without requiring de novo viral protein synthesis . In temporal expression studies, FV3-094L showed significant upregulation (6.344-fold) at 2 hours post-infection compared to uninfected cells, with expression levels of 5.593-fold at 4 hours and 54.74-fold at 9 hours post-infection . As an IE gene, it likely plays a role in the initial stages of viral infection, potentially involved in regulatory functions, nucleic acid metabolism, or immune evasion mechanisms.

How is FV3-094L classified within the FV3 genome and virus life cycle?

FV3-094L is classified as an immediate early stable (IE-S) gene based on comprehensive transcriptome analyses . FV3 genes are expressed in a coordinated fashion during infection, with sequential appearance of immediate early (IE), delayed early (DE), and late (L) viral transcripts . The IE-S designation indicates that FV3-094L transcripts appear early in infection and remain detectable throughout the infection cycle. The temporal classification was determined through multiple approaches including time-course studies, cycloheximide inhibition assays, and temperature-sensitive mutant infections, which collectively provide robust validation of its IE-S status .

What are the main challenges in studying uncharacterized viral proteins like FV3-094L?

Studying uncharacterized viral proteins like FV3-094L presents several methodological challenges. First, the absence of well-defined functions makes experimental design complex, requiring multiple approaches to elucidate potential roles. Second, the lack of structural information necessitates computational prediction followed by empirical validation. Third, these proteins often lack obvious homologs in well-characterized systems, making comparative analyses difficult. Fourth, generating functional recombinant proteins may be challenging if the native protein has toxic effects or requires virus-specific post-translational modifications. Finally, determining biological relevance requires development of appropriate in vitro and in vivo systems that accurately model ranavirus-host interactions across different amphibian species .

How does FV3-094L expression vary across different infected tissues?

Based on transcriptomic analyses of FV3-infected Xenopus laevis tissues, viral gene expression patterns, including FV3-094L, show tissue-dependent variation . In tissues such as intestine, liver, spleen, lung, and especially kidney, FV3 transcripts demonstrate full-genome coverage with approximately 10× depth on both positive and negative strands . In contrast, tissues like thymus, skin, and muscle show only partial transcript coverage, suggesting less efficient viral replication . While the search results don't specify FV3-094L expression levels in each tissue, as an immediate early gene, it likely follows the general tissue tropism pattern observed for other FV3 immediate early genes, with highest expression in kidney and other highly permissive tissues. Tissue-specific variation might reflect differences in cellular receptors, immune responses, or metabolic environments that impact viral entry and replication efficiency.

What experimental approaches can effectively measure FV3-094L expression kinetics?

Multiple complementary approaches can effectively measure FV3-094L expression kinetics:

  • RNA-Seq analysis: Provides comprehensive transcriptome profiling across time points post-infection, capturing quantitative expression changes as demonstrated in existing FV3 studies .

  • Quantitative RT-PCR (qRT-PCR): Enables precise quantification of FV3-094L transcript levels over time, with high sensitivity for detecting low-abundance transcripts .

  • Microarray analysis: Used successfully to determine temporal class of all 98 FV3 ORFs, allowing simultaneous monitoring of multiple viral genes .

  • Northern blot analysis: Provides information about transcript size and stability, helping confirm the "stable" classification of FV3-094L transcripts.

  • Reporter gene assays: Construct with FV3-094L promoter region driving expression of reporters like luciferase to study transcriptional regulation in real-time.

  • Cycloheximide blocking: Specifically identifies immediate early genes by blocking protein synthesis, allowing only IE genes to be transcribed .

  • Temperature-sensitive mutant infections: Using mutants defective in late gene expression helps distinguish between IE/DE and late genes .

These approaches can be combined to generate comprehensive expression profiles and validate temporal classification.

What regulatory elements control FV3-094L expression?

While specific regulatory elements controlling FV3-094L expression have not been fully characterized, its classification as an immediate early gene provides insights into potential control mechanisms. Immediate early genes in DNA viruses typically contain promoter elements recognized by host transcription machinery without requiring de novo viral protein synthesis . Based on studies of other DNA viruses and iridoviruses, several potential regulatory features may control FV3-094L expression:

  • TATA box and initiator elements: Likely present in the promoter region to recruit host RNA polymerase II.

  • Transcription factor binding sites: May include motifs for cellular transcription factors active in host cells during early infection.

  • Viral transcription activation sequences: These would be recognized by virion-associated proteins that enter with the infecting virus.

  • RNA polymerase II-dependent transcription: FV3 immediate early genes utilize host RNA polymerase II, potentially modified by a virion-associated protein (VATT) .

Comparative analysis with other FV3 immediate early genes might reveal conserved upstream regulatory sequences. Additionally, FV3 encodes homologues of RNA polymerase II subunits and related factors that could potentially influence immediate early gene expression, including proteins similar to Rpb7, Rpb5, and FCP1 phosphatase that might modify host transcriptional machinery .

What computational tools are most effective for predicting FV3-094L protein structure?

For predicting the structure of uncharacterized viral proteins like FV3-094L, researchers should employ a multi-tool approach:

  • AlphaFold2/RoseTTAFold: These AI-based structure prediction tools have revolutionized protein structure prediction with near-experimental accuracy, particularly valuable for proteins lacking close homologs.

  • I-TASSER/Phyre2: These threading-based methods can identify distant structural homologs even when sequence identity is low.

  • SWISS-MODEL: Useful for homology modeling if P8.141C or other similar proteins have resolved structures.

  • JPred/PSIPRED: Secondary structure prediction tools to identify alpha-helices, beta-sheets, and disordered regions.

  • TMHMM/TOPCONS: For predicting transmembrane domains if FV3-094L is potentially membrane-associated.

  • NetNGlyc/NetOGlyc: For glycosylation site prediction, important for viral envelope proteins.

  • ConSurf/EVcouplings: To identify evolutionarily conserved residues and coevolving amino acid pairs that might indicate functional importance.

  • DisEMBL/PONDR: For predicting intrinsically disordered regions that might be involved in protein-protein interactions.

  • Molecular dynamics simulations: To analyze stability of predicted structures and potential conformational changes.

The P8.141C-like designation of FV3-094L provides a starting point for homology-based approaches, though verification through experimental methods remains essential.

How can researchers experimentally determine the structure of FV3-094L?

Experimental determination of FV3-094L structure requires a comprehensive approach:

  • Protein Expression Systems:

    • Prokaryotic (E. coli) systems for high-yield but may lack post-translational modifications

    • Eukaryotic systems (insect cells, yeast) for better folding and modifications

    • Cell-free systems for potentially toxic proteins

  • Purification Strategy:

    • Affinity tags (His, GST, MBP) optimization for solubility and yield

    • Size exclusion chromatography for homogeneity

    • Ion exchange chromatography for purity

  • Structural Determination Methods:

    • X-ray crystallography: Requires high-quality crystals; provides atomic resolution

    • Cryo-electron microscopy: Increasingly powerful for medium-sized proteins without crystallization

    • NMR spectroscopy: Valuable for smaller proteins and providing dynamic information

    • Small-angle X-ray scattering (SAXS): For low-resolution envelope structure in solution

  • Validation Approaches:

    • Circular dichroism: To confirm secondary structure content

    • Limited proteolysis: To identify domain boundaries and flexible regions

    • Thermal shift assays: To assess stability and ligand binding

    • Crosslinking mass spectrometry: To identify intra-molecular contacts

  • Functional Domain Mapping:

    • Truncation constructs to identify minimal functional domains

    • Alanine scanning mutagenesis for critical residues

    • Hydrogen/deuterium exchange for identifying solvent-exposed regions

Success depends on obtaining sufficient quantities of properly folded protein, which may require optimization of expression conditions and purification protocols specific to FV3-094L properties.

How does FV3-094L compare with homologous proteins in other ranaviruses?

Comparative analysis of FV3-094L with homologous proteins in other ranaviruses can provide valuable insights into its conservation, evolution, and potential function. While specific comparative data for FV3-094L is limited in the search results, the following approach would be most informative:

  • Sequence Homology Assessment:

    • FV3-094L is described as a P8.141C-like protein , suggesting sequence similarity to proteins in related viruses

    • BLAST analysis against other ranavirus genomes would identify orthologs and paralogs

    • Multiple sequence alignment would reveal conserved motifs or domains

  • Evolutionary Conservation:

    • Phylogenetic analysis could determine whether FV3-094L is conserved across the Iridoviridae family or specific to ranaviruses

    • dN/dS ratio analysis would identify regions under selective pressure, suggesting functional importance

    • Synteny analysis might reveal conserved genomic context

  • Functional Inference:

    • Comparison with characterized homologs in other iridoviruses

    • As an immediate early gene (IE-S) , comparison with other IE genes in related viruses could suggest functional parallels

    • Analysis of presence/absence patterns across viral strains with varying virulence

  • Structural Comparison:

    • Homology modeling based on any characterized structural homologs

    • Domain architecture comparison across ranavirus homologs

    • Identification of conserved post-translational modification sites

The available data indicates that comparative genomic and transcriptomic analyses have been instrumental in classifying FV3 genes, including FV3-094L , suggesting this approach would be valuable for further characterization.

What are the most efficient approaches to determine FV3-094L function?

Determining the function of FV3-094L requires an integrated multi-method approach:

  • Genetic Manipulation:

    • Gene knockout/knockdown via CRISPR-Cas9 or antisense morpholinos to assess impact on viral replication

    • Site-directed mutagenesis of predicted functional domains

    • Construction of chimeric/tagged versions for localization and interaction studies

  • Expression Analysis:

    • Temporal expression profiling in different cell types and tissues

    • Subcellular localization using immunofluorescence or fluorescent protein tagging

    • Correlation with specific stages of viral replication cycle

  • Protein Interaction Studies:

    • Immunoprecipitation followed by mass spectrometry to identify binding partners

    • Yeast two-hybrid or mammalian two-hybrid screening

    • Protein-protein interaction validation via FRET, BiFC, or pull-down assays

    • Chromatin immunoprecipitation (ChIP) if DNA-binding activity is suspected

  • Functional Assays:

    • Given its IE-S classification , testing for effects on viral gene expression

    • Assessing impact on host immune response pathways

    • Evaluating effects on host cell metabolism or viability

    • Testing for enzymatic activities (kinase, phosphatase, etc.)

  • Comparative Approaches:

    • Heterologous expression in model systems

    • Functional complementation assays with related viral proteins

    • Cross-species infection studies to assess conservation of function

By integrating data from these complementary approaches, researchers can develop testable hypotheses about FV3-094L function and its role in viral pathogenesis.

Based on its temporal expression pattern, what potential functions might FV3-094L serve?

As an immediate early stable (IE-S) gene with significant expression early in infection (6.344-fold increase at 2 hours post-infection) , FV3-094L likely plays a role in establishing productive infection. Based on temporal expression patterns and knowledge of other DNA virus immediate early genes, several potential functions can be hypothesized:

  • Transcriptional Regulation:

    • Modulation of host transcription machinery to favor viral gene expression

    • Activation of viral delayed early gene expression

    • Potential interaction with RNA polymerase II components, as Iridoviruses encode homologs of RNA polymerase subunits

  • Host Defense Modulation:

    • Interference with host immune signaling pathways

    • Suppression of host antiviral responses

    • This aligns with findings that FV3 appears to have acquired molecular mimics interfering with host interferon signaling

  • Viral Replication Complex Formation:

    • Recruitment of host factors needed for viral genome replication

    • Preparation of nuclear or cytoplasmic compartments for viral replication

  • Cell Cycle Manipulation:

    • Modification of host cell cycle to create favorable conditions for viral replication

    • Prevention of apoptosis to maintain cell viability during viral production

  • RNA Processing/Stability Control:

    • The "stable" designation of its transcript suggests potential roles in RNA metabolism

    • Possible involvement in processing or stability of viral or host transcripts

The persistent expression throughout infection (increasing to 54.74-fold by 9 hours) suggests its function may be required throughout the viral replication cycle, unlike transient IE genes that are only needed briefly to initiate infection.

How might post-translational modifications affect FV3-094L function?

Post-translational modifications (PTMs) likely play crucial roles in regulating FV3-094L function, localization, and interactions, though specific modifications have not been characterized in the available search results. Based on knowledge of viral protein regulation, several potential PTM mechanisms may be relevant:

  • Phosphorylation:

    • May regulate activity, localization, or protein-protein interactions

    • Could be mediated by viral kinases or host kinases

    • Often serves as a molecular switch for immediate early viral proteins

    • Potential sites could be predicted using tools like NetPhos, GPS, or PhosphoSitePlus

  • Ubiquitination/SUMOylation:

    • Might regulate protein stability and turnover

    • Could mediate nuclear-cytoplasmic shuttling

    • May affect interactions with host factors

    • FV3 encodes proteins that could potentially manipulate ubiquitin pathways

  • ADP-ribosylation:

    • Several DNA viruses utilize this modification to regulate host-pathogen interactions

    • Could affect interactions with nucleic acids or other proteins

  • Proteolytic Processing:

    • Limited proteolysis might activate or regulate protein function

    • Could generate multiple functional products from a single precursor

  • Glycosylation:

    • If FV3-094L interacts with membrane components or is secreted

    • Might affect protein stability or immune recognition

Experimental approaches to investigate PTMs of FV3-094L should include:

  • Mass spectrometry-based proteomics to identify modifications

  • Site-directed mutagenesis of predicted modification sites

  • Use of modification-specific inhibitors to assess functional impacts

  • Co-expression with viral or cellular enzymes that mediate specific modifications

Understanding these modifications would provide insights into how FV3-094L activity is regulated during infection and potentially identify targets for intervention.

How might FV3-094L contribute to viral immune evasion strategies?

As an immediate early gene, FV3-094L could play a significant role in viral immune evasion, particularly given evidence that ranaviruses like FV3 have acquired molecular mimics that interfere with host interferon (IFN) signaling . Several potential mechanisms warrant investigation:

  • Interferon Pathway Interference:

    • FV3-094L might target components of the interferon response pathway, similar to other FV3 genes that encode proteins containing viral mimicking conserved domains found in host IFN regulatory factors (IRFs) and IFN receptors

    • Could potentially block JAK-STAT signaling downstream of IFN receptor activation

    • Might inhibit pattern recognition receptors that detect viral nucleic acids

  • Antigen Presentation Modulation:

    • May interfere with MHC class I pathway components to prevent viral peptide presentation

    • Could target immunoproteasome function or peptide transport

    • This would help evade CD8+ T cell responses in infected amphibians

  • Inflammatory Signaling Disruption:

    • Potential inhibition of NF-κB or other inflammatory transcription factors

    • Could prevent production of pro-inflammatory cytokines and chemokines

    • Might target specific pattern recognition receptor signaling pathways

  • Apoptosis Regulation:

    • May prevent premature cell death to allow complete viral replication

    • FV3 genome contains genes with similarity to anti-apoptotic factors (e.g., an MCL-1 region in ORF97R)

    • FV3-094L could potentially interact with host apoptotic machinery

  • Complement Evasion:

    • Possible interaction with complement components to prevent virion neutralization

    • Could protect infected cells from complement-mediated lysis

Research approaches should include comparative analyses with known viral immune evasion proteins, protein-protein interaction studies with host immune components, and functional assays measuring host response factors in the presence or absence of FV3-094L expression.

What role might FV3-094L play in the virus's ability to infect multiple host species?

FV3's ability to infect diverse hosts across amphibians, fish, and reptiles suggests its proteins, potentially including FV3-094L, have evolved mechanisms to function effectively across varied cellular environments. Several hypotheses regarding FV3-094L's potential contribution to this broad host range include:

  • Conserved Host Target Interaction:

    • FV3-094L may interact with highly conserved cellular factors present across vertebrate species

    • As an immediate early protein, it might target fundamental aspects of cellular machinery that have not diverged significantly among potential hosts

    • Could modulate basic transcriptional or translational processes conserved across vertebrates

  • Adaptive Protein Conformation:

    • May possess structural flexibility allowing it to adapt to homologous but distinct host factors

    • Critical binding interfaces might contain residues that accommodate variations in host protein sequences

  • Immune Evasion Across Species:

    • Could target conserved components of innate immunity present in diverse hosts

    • Immediate early expression would allow suppression of host defenses before they can restrict viral replication

    • The evidence that FV3 has acquired molecular mimics interfering with host IFN signaling suggests immune evasion factors like FV3-094L might contribute to cross-species infection

  • Host Range Determination:

    • Variations in FV3-094L sequence between viral strains might correlate with host range differences

    • Functional polymorphisms might adapt the protein to specific host environments

    • Comparative analysis of FV3-094L across FV3 strains with different host preferences could test this hypothesis

  • Tissue Tropism Influence:

    • Could contribute to the observed variation in viral gene expression across different host tissues

    • May interact with tissue-specific factors to promote optimal replication in target tissues

Research approaches should include comparative functional studies in cell lines from diverse host species, mutagenesis to identify host-specificity determinants, and correlation of sequence variation with host range among field isolates.

How might interactions between FV3-094L and host proteins be leveraged for antiviral development?

Understanding interactions between FV3-094L and host proteins could reveal valuable targets for antiviral development against ranaviruses, which are significant pathogens threatening amphibian biodiversity worldwide. Several strategic approaches could be pursued:

  • Structural-Based Inhibitor Design:

    • If critical interactions between FV3-094L and host proteins are identified, small molecule inhibitors could be designed to disrupt these interfaces

    • Crystallographic or cryo-EM structures of FV3-094L-host protein complexes would facilitate structure-based drug design

    • Virtual screening against binding pockets could identify lead compounds for optimization

  • Peptide-Based Inhibitors:

    • Synthetic peptides derived from host protein interaction domains could competitively inhibit FV3-094L binding

    • Cell-penetrating peptides could be engineered to target intracellular interactions

    • Stapled peptides might provide increased stability and cellular uptake

  • Dominant Negative Approaches:

    • Modified versions of FV3-094L could be designed to compete with wild-type protein

    • These decoys would bind host targets but fail to execute viral functions

    • Could be delivered via modified attenuated viruses or other vector systems

  • Host-Directed Therapeutics:

    • If FV3-094L targets host pathways that can be modulated without severe toxicity, host-directed therapeutics might be effective

    • This approach might have broader spectrum activity against multiple ranavirus species

    • Could potentially activate antiviral host responses normally suppressed by FV3-094L

  • DNA/RNA-Based Interventions:

    • CRISPR-Cas systems could be engineered to target the FV3-094L gene

    • Antisense oligonucleotides or siRNAs could suppress FV3-094L expression

    • These genomic/transcriptomic approaches would need effective delivery systems

  • Immune-Based Therapies:

    • If FV3-094L is exposed on infected cells or virions, antibody-based therapies might be effective

    • Understanding how FV3-094L modulates host immunity could reveal pathways for immunomodulatory interventions

Development of such interventions would require thorough validation in cell culture and appropriate animal models, with careful consideration of environmental impacts for any treatments intended for wild amphibian populations.

What are the best expression systems for producing recombinant FV3-094L for structural and functional studies?

Selecting the optimal expression system for recombinant FV3-094L requires consideration of multiple factors to ensure proper folding, solubility, and potential post-translational modifications. Based on experience with viral proteins, several systems merit consideration:

  • Bacterial Expression Systems:

    • E. coli BL21(DE3) variants: Traditional workhorse for protein expression

    • E. coli Rosetta strains: Provide rare codons that might be present in viral genes

    • E. coli SHuffle/Origami: Enhanced disulfide bond formation if required

    • Advantages: High yield, cost-effective, rapid expression

    • Limitations: Potential folding issues, lack of eukaryotic post-translational modifications

    • Optimization strategies: Fusion tags (MBP, SUMO, GST), lower temperature expression, co-expression with chaperones

  • Yeast Expression Systems:

    • Pichia pastoris/Saccharomyces cerevisiae: Eukaryotic environment with simpler growth requirements

    • Advantages: Proper folding, some post-translational modifications, secretion possible

    • Limitations: Lower yields than bacteria, longer production time

  • Insect Cell Systems:

    • Sf9/Sf21/High Five cells with baculovirus vectors: Excellent for viral proteins

    • Advantages: Near-native folding, comprehensive post-translational modifications

    • Limitations: More complex, higher cost, requires baculovirus preparation

  • Mammalian Expression Systems:

    • HEK293/CHO cells: Most native-like environment for vertebrate viral proteins

    • Advantages: Most authentic post-translational modifications and folding

    • Limitations: Highest cost, lowest typical yields, most complex

  • Cell-Free Systems:

    • E. coli/wheat germ/rabbit reticulocyte lysates: Rapid expression without cellular constraints

    • Advantages: Quick results, allows expression of toxic proteins

    • Limitations: Limited scale, expensive for large-scale production

For FV3-094L specifically, a progressive approach is recommended:

  • Begin with E. coli systems using solubility-enhancing tags

  • If solubility issues arise, shift to insect cell expression

  • For detailed functional studies requiring authentic modifications, consider mammalian expression

  • Use cell-free systems for preliminary interaction studies or if the protein proves toxic to expression hosts

The choice should be guided by the specific experimental goals, required protein quantity, and downstream applications.

What challenges might researchers encounter when creating FV3-094L knockouts or mutants, and how can they be addressed?

Creating FV3-094L knockouts or mutants presents several technical challenges that must be addressed through careful experimental design:

  • Essential Gene Function Challenges:

    • If FV3-094L is essential for viral replication, complete knockouts may not be viable

    • Solution: Create conditional knockouts using inducible systems, temperature-sensitive mutants, or partial functional mutations

    • Approach: Employ complementation systems where the wild-type gene is supplied in trans while mutant virus is propagated

  • Genomic Editing Challenges:

    • Large DNA virus genomes are more difficult to manipulate than RNA viruses

    • Solution: Utilize bacterial artificial chromosome (BAC) systems containing the full FV3 genome

    • Approach: Perform homologous recombination in E. coli followed by virus reconstitution in eukaryotic cells

    • Alternative: CRISPR-Cas9 technology can be adapted for direct editing of viral genomes during infection

  • Overlapping Gene Issues:

    • Viral genomes often contain overlapping genes or regulatory elements

    • Solution: Use silent mutations or precise editing to avoid disrupting adjacent genes

    • Approach: Careful bioinformatic analysis to identify potential overlapping features prior to design

  • Mutation Verification Challenges:

    • Confirming the specific mutation without unwanted secondary mutations

    • Solution: Whole genome sequencing of mutant viruses

    • Approach: Create independent mutant lines and confirm consistent phenotypes

  • Phenotype Analysis Complexities:

    • As an immediate early gene , effects may be subtle or masked by redundant functions

    • Solution: Employ multiple assays at different stages of viral replication

    • Approach: Analyze both single-step and multi-step growth curves, transcriptome changes, and host response alterations

  • Reversion Concerns:

    • Mutant viruses may revert to wild-type during propagation

    • Solution: Include marker mutations or larger deletions that are unlikely to revert

    • Approach: Frequent genotype verification during experimental work

  • Appropriate Cell Systems:

    • Need for permissive cell lines that support both wild-type and potentially attenuated mutant viruses

    • Solution: Test multiple amphibian cell lines (e.g., FHM cells used in transcriptomic studies )

    • Approach: Consider developing conditional cell lines expressing FV3-094L for propagation of defective viruses

These challenges can be addressed through careful planning, appropriate controls, and the use of complementary approaches to validate findings.

What are the most informative comparative genomics approaches for analyzing FV3-094L across different viral isolates?

Comparative genomics approaches provide powerful insights into the evolution, function, and host-adaptation of viral proteins like FV3-094L. The most informative strategies include:

  • Whole Genome Alignment and Synteny Analysis:

    • Compare genomic context of FV3-094L across ranavirus isolates

    • Examine conservation of adjacent genes and regulatory elements

    • Identify potential operon-like structures or co-regulated gene clusters

    • Tools: Mauve, ACT (Artemis Comparison Tool), SynMap

  • Ortholog Identification and Classification:

    • Identify true orthologs versus paralogs across ranavirus species

    • Establish presence/absence patterns across diverse isolates

    • Correlate with host range, virulence, or geographic distribution

    • Tools: OrthoMCL, OrthoFinder, BLAST-based comparative approaches

  • Selective Pressure Analysis:

    • Calculate dN/dS ratios to identify regions under purifying or positive selection

    • Identify codon-specific selection signatures using methods like PAML, FUBAR, or MEME

    • Compare selection patterns between isolates from different host species

    • Correlate with known or predicted functional domains

  • Recombination and Horizontal Gene Transfer Detection:

    • Identify potential recombination events affecting FV3-094L

    • Assess evidence for horizontal acquisition from hosts or other viruses

    • Tools: RDP4, GARD, SimPlot

  • Structural Variation Analysis:

    • Identify insertions, deletions, duplications affecting FV3-094L

    • Characterize strain-specific variations that might affect function

    • Analyze impact on protein domains and predicted structure

    • Tools: SVDetect, Pindel, customized structural variant pipelines

  • Comprehensive Phylogenetic Analysis:

    • Construct gene trees for FV3-094L and compare to species trees

    • Identify potential incongruences suggesting unique evolutionary history

    • Include related genes from other virus families to identify distant homologs

    • Tools: RAxML, MrBayes, IQ-TREE, PhyML

  • Regulatory Element Comparison:

    • Analyze promoter regions across isolates to identify conserved motifs

    • Compare temporal expression patterns (IE-S classification) across strains

    • Identify potential transcription factor binding sites

    • Tools: MEME Suite, RSAT, PhyloGibbs

The combination of these approaches can provide robust insights into the evolution and adaptation of FV3-094L, particularly when integrated with experimental data on protein function and host interactions.

How should researchers interpret contradictory results regarding FV3-094L function between different host species?

Contradictory results regarding FV3-094L function across different host species require systematic analysis and interpretation. These discrepancies may reflect important biological phenomena rather than experimental errors:

  • Host-Specific Adaptation Hypothesis:

    • FV3-094L may have evolved distinct functions or regulatory mechanisms in different host species

    • Approach: Map variations in sequence or expression to specific host-interaction domains

    • Validation: Create chimeric proteins with domains from different host-adapted strains and test function

  • Contextual Dependency Framework:

    • Function may depend on presence of specific host factors that vary between species

    • Approach: Perform comparative proteomics to identify differential binding partners

    • Validation: Co-express identified host factors in heterologous systems to rescue function

  • Methodological Evaluation:

    • Different experimental systems may influence results

    • Approach: Standardize methodologies across host systems

    • Validation: Replicate key findings using identical protocols in different laboratories

  • Developmental and Tissue-Specific Effects:

    • FV3-094L function may vary with developmental stage or tissue type

    • Approach: Systematic comparison across developmental stages and tissues

    • Validation: Create tissue-specific expression systems to isolate variables

  • Quantitative versus Qualitative Differences Analysis:

    • Function may be conserved but efficiency may differ

    • Approach: Develop quantitative assays for FV3-094L activity

    • Validation: Dose-response studies with controlled expression levels

  • Redundancy Assessment:

    • Alternative pathways may compensate for FV3-094L function in some hosts

    • Approach: Systems biology analysis of affected pathways

    • Validation: Combinatorial knockdown of redundant factors

  • Integration Framework:

    • Create a unified model incorporating species-specific variables

    • Approach: Mathematical modeling of host-pathogen interactions

    • Validation: Test model predictions with targeted experiments

This interpretive framework transforms contradictory results into valuable insights about host-specific viral protein functions, potentially revealing adaptations that contribute to FV3's broad host range .

What criteria should be used to evaluate the physiological relevance of in vitro findings about FV3-094L?

Evaluating the physiological relevance of in vitro findings about FV3-094L requires rigorous criteria to bridge laboratory observations with real-world infection dynamics:

  • Concentration/Expression Level Assessment:

    • Key Question: Do experimental expression levels match those observed during natural infection?

    • Validation Approach: Compare recombinant protein levels with quantified expression in infected tissues

    • Metric: Within 2-5 fold of levels observed in transcriptomic/proteomic studies of infected tissues

    • Tool: Quantitative Western blotting or mass spectrometry against natural infection samples

  • Temporal Dynamics Correlation:

    • Key Question: Do experimental time points reflect the IE-S expression profile observed in vivo?

    • Validation Approach: Time-course comparisons between in vitro and in vivo systems

    • Metric: Similar expression kinetics relative to other viral genes

    • Tool: RT-qPCR validation comparing cell culture and tissue samples

  • Cellular/Tissue Context Evaluation:

    • Key Question: Are observations consistent across relevant cell types/tissues?

    • Validation Approach: Test in multiple amphibian cell lines and primary cultures

    • Metric: Consistency across tissues showing full viral genome expression

    • Tool: Ex vivo tissue culture systems from susceptible amphibian species

  • Host Response Integration:

    • Key Question: Do observations account for host immune and stress responses?

    • Validation Approach: Include immune factors in experimental design

    • Metric: Reproducibility in immune-competent systems

    • Tool: Co-culture systems with immune cells or immune factors

  • Temperature and Environmental Condition Relevance:

    • Key Question: Do experimental conditions reflect natural host environments?

    • Validation Approach: Test function across temperature ranges experienced by hosts

    • Metric: Activity at temperatures relevant to amphibian habitats

    • Tool: Temperature-controlled assay systems

  • Cross-Validation Requirements:

    • Key Question: Are findings reproducible across multiple experimental approaches?

    • Validation Approach: Triangulate results using independent methodologies

    • Metric: Convergent evidence from at least three distinct experimental systems

    • Tool: Multi-dimensional data integration frameworks

  • In Vivo Correlation Standards:

    • Key Question: Can key findings be verified in infection models?

    • Validation Approach: Test predictions in laboratory infection models

    • Metric: Phenotype consistency between in vitro and in vivo systems

    • Tool: Tadpole and adult amphibian infection models with mutant viruses

By systematically applying these criteria, researchers can strengthen the physiological relevance of their findings and advance understanding of FV3-094L's authentic role in infection.

How can transcriptomic data about FV3-094L expression be integrated with proteomics and functional assays to generate comprehensive understanding?

Integrating transcriptomic, proteomic, and functional data requires sophisticated approaches to build a comprehensive understanding of FV3-094L:

  • Multi-omics Data Integration Framework:

    • Core Strategy: Establish temporal relationships between transcript levels , protein abundance, and observed functions

    • Implementation: Time-series analysis correlating RNA-Seq, proteomics, and functional assays

    • Analytical Tools: WGCNA, mixOmics, DIABLO for multi-omics data integration

    • Visualization: Sankey diagrams or heatmaps showing relationships across data types

  • Regulatory Network Reconstruction:

    • Core Strategy: Use transcriptomic data (IE-S classification) to position FV3-094L in viral gene regulatory networks

    • Implementation: Bayesian network analysis incorporating expression data from wild-type and mutant infections

    • Analytical Tools: ARACNE, CLR, or GENIE3 algorithms

    • Validation: ChIP-Seq or similar approaches to confirm predicted regulatory interactions

  • Protein Interaction Mapping:

    • Core Strategy: Correlate transcriptomic expression patterns with proteomic interaction data

    • Implementation: Affinity purification-mass spectrometry at time points matching transcriptomic data

    • Analytical Tools: STRING, IntAct, or custom interaction databases

    • Visualization: Dynamic protein interaction networks across infection stages

  • Structure-Function Correlation:

    • Core Strategy: Link expression patterns to structural features and functional domains

    • Implementation: Domain-specific mutagenesis guided by expression pattern data

    • Analytical Tools: Integrative modeling platforms combining structural predictions with functional data

    • Validation: Structure-based functional assays targeting domains expressed at different infection stages

  • Host Response Correlation:

    • Core Strategy: Analyze how FV3-094L expression correlates with changes in host transcriptome/proteome

    • Implementation: Parallel RNA-Seq of viral and host transcripts during infection

    • Analytical Tools: Causal inference methods like Granger causality or dynamic Bayesian networks

    • Validation: Host factor perturbation experiments at key expression timepoints

  • Quantitative Modeling Approaches:

    • Core Strategy: Develop mathematical models incorporating expression kinetics and functional data

    • Implementation: Ordinary differential equations modeling virus-host dynamics

    • Analytical Tools: Systems biology platforms like COPASI or CellDesigner

    • Validation: Experimental testing of model predictions under various perturbations

  • Comparative Analysis Framework:

    • Core Strategy: Compare integrated datasets across different viral strains (e.g., FV3-WT vs. FV3-Δ64R)

    • Implementation: Differential expression and network analysis between strains

    • Analytical Tools: Differential network biology approaches

    • Validation: Engineered mutations to test hypothesized strain differences

This integrated approach transforms disparate data types into a coherent understanding of FV3-094L's role in the viral replication cycle and host-pathogen interactions.

What are the most promising future research directions for understanding FV3-094L?

Based on current knowledge and gaps identified in the search results, several promising research directions emerge for furthering our understanding of FV3-094L:

  • Structure-Function Analysis:

    • Determine the three-dimensional structure of FV3-094L through X-ray crystallography or cryo-EM

    • Map functional domains through systematic mutagenesis

    • Identify critical residues for protein-protein interactions or enzymatic activities

  • Host-Pathogen Interaction Networks:

    • Identify host binding partners through proteomics approaches

    • Characterize the impact of FV3-094L on host cell signaling pathways

    • Develop systems biology models of FV3-094L's role in the infection process

  • Temporal Dynamics and Regulation:

    • Further characterize the mechanisms controlling FV3-094L's immediate early expression

    • Identify regulatory elements in the promoter region

    • Understand how FV3-094L contributes to the cascade of viral gene expression

  • Comparative Virology Approaches:

    • Compare FV3-094L function across different ranavirus isolates

    • Examine adaptation to different host species

    • Identify evolutionary pressures shaping FV3-094L sequence and function

  • Immune Evasion Mechanisms:

    • Investigate FV3-094L's potential role in the viral mimicry of host interferon signaling components

    • Characterize interactions with host immune response pathways

    • Determine species-specific differences in immune modulation

  • Therapeutic Target Development:

    • Assess FV3-094L as a potential target for anti-ranavirus interventions

    • Develop small molecule inhibitors or peptide-based approaches

    • Evaluate in both in vitro and in vivo infection models

  • Advanced Genetic Approaches:

    • Create conditional knockouts to study essential functions

    • Develop reporter systems to monitor FV3-094L expression and localization in real-time

    • Apply CRISPR-Cas9 technology for precise genome editing of FV3

These research directions would significantly advance our understanding of this uncharacterized protein and potentially contribute to broader knowledge of ranavirus pathogenesis and host-virus interactions.

How does understanding FV3-094L contribute to broader knowledge of viral evolution and host-pathogen interactions?

Understanding FV3-094L provides valuable insights into fundamental aspects of viral evolution and host-pathogen interactions that extend beyond ranavirus biology:

  • Viral Mimicry Evolution:

    • FV3-094L may represent part of the virus's molecular mimicry arsenal, similar to other FV3 proteins that contain domains mimicking host interferon (IFN) regulatory factors and IFN receptors

    • Studying its evolution could reveal mechanisms by which viruses acquire host-like domains

    • May provide insights into convergent evolution of immune evasion strategies across viral families

  • Host Range Determinants:

    • As an immediate early gene , FV3-094L likely plays a role in establishing initial infection

    • Understanding its function could help explain FV3's broad host range across amphibians, fish, and reptiles

    • Could reveal fundamental constraints and opportunities in viral host switching

  • Viral Gene Regulation Paradigms:

    • The temporal regulation of FV3-094L as an IE-S gene represents a model for understanding complex gene regulation in large DNA viruses

    • Provides insights into how viruses coordinate gene expression for efficient replication

    • May reveal novel regulatory mechanisms applicable to other viral systems

  • Evolutionary Arms Race Dynamics:

    • Studying FV3-094L's interactions with host factors could illuminate coevolutionary dynamics

    • Sequence analysis across viral isolates from different hosts may reveal signatures of selection

    • Could identify molecular interfaces under positive selection, indicating host-specific adaptation

  • Emerging Disease Mechanisms:

    • FV3 contributes to catastrophic amphibian declines worldwide

    • Understanding key viral factors like FV3-094L may help explain emerging virulence

    • Could inform surveillance and intervention strategies for wildlife conservation

  • Fundamental Viral Replication Strategies:

    • As part of a large DNA virus, FV3-094L's function may reveal conserved strategies used by diverse viral groups

    • Could identify essential virus-host interactions that represent vulnerability points

    • May reveal novel mechanisms by which viruses manipulate cellular machinery

  • Comparative Immunology Insights:

    • FV3-094L's potential role in immune evasion across different host species could highlight conserved and divergent aspects of vertebrate immunity

    • Might reveal previously unrecognized immune pathways in lower vertebrates

    • Could identify fundamental constraints in host-pathogen recognition systems

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.